Bridging the Gap from
Approval to Access
Empowering the 95% of MedTech innovators to navigate the complexity of reimbursement and market access.
The Challenge: The Evidence Gap
A structural misalignment exists between regulatory requirements and payer expectations. Startups often optimize for regulatory clearance, leaving a critical gap in the economic evidence required for reimbursement.
Regulatory Clearance
FocusSafety & Efficacy
MilestoneCE Mark / FDA Clearance
Necessary for market entry, but insufficient for payment.
Market Access
FocusValue & Cost-Effectiveness
MilestoneReimbursement / Coverage
The critical step for commercial viability and adoption.
The Reimbursement Hurdle
This "Evidence Gap" creates coverage uncertainty. Our mission is to help companies bridge this gap by integrating market access strategy early in the development lifecycle.
Professional Market Access Infrastructure
We provide scalable, expert-augmented infrastructure to democratize access to high-quality regulatory and reimbursement intelligence.
Early Integration
Incorporate reimbursement requirements into clinical trial design to ensure data utility for both regulators and payers.
Structured Intelligence
Leverage structured data and AI to rapidly synthesize evidence and identify relevant reimbursement pathways.
Scalable Expertise
Access professional-grade tools and expert networks that scale with your company's growth and needs.
Who We Serve
Our platform is designed to align the incentives of the entire MedTech ecosystem.
Innovators & Startups
- •Accelerate Path to Patients: Generate critical reimbursement evidence early in your development lifecycle.
- •Budget Optimization: Access expert-grade HEOR tools without the traditional consultancy price tag.
- •Regulatory Alignment: Ensure your clinical evidence supports both regulatory approval and payer value requirements.
HEOR Experts
- •Practice Augmentation: Let AI handle the manual 80% of drafting so you can focus on high-value strategy.
- •Scalable Infrastructure: Serve more clients with consistent quality using our standardized frameworks.
- •Future-Proofing: Position your consultancy at the forefront of the AI-augmented market access revolution.
Investors
- •Portfolio De-Risking: Quantify reimbursement risk and market potential before you invest.
- •Value Acceleration: Ensure your portfolio companies avoid the "Second Valley of Death" and reach commercial milestones faster.
- •Data-Driven Decisions: Move beyond qualitative opinion to quantitative assessment of market access viability.
Join the Network
Connect with a community of HEOR experts, innovators, and investors dedicated to accelerating patient access to medical technology.